Friday, August 29, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Conflicting Analyst Opinions on Aris Water Solutions Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_Credit
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Wells Fargo analyst Praneeth Satish upgraded Aris Water Solutions to an Equal-Weight rating and increased the price target to $11.

__________

However, there are conflicting opinions among analysts regarding the price target for Aris Water Solutions. J.P. Morgan set a target of $14.00, Stifel Nicolaus at $17.00, and Citi at $13.00. The consensus rating for Aris Water Solutions is a Moderate Buy based on the assessments of 2 Wall Street analysts.

__________

The average twelve-month price forecast for Aris Water Solutions stands at $13.86, with a high target of $20.00 and a low of $9.00. Analysts predict a mean target price of $14.18, indicating a potential upside of 16.44%.

__________

In addition, Evercore ISI adjusted the price target for Aris Water Solutions to $20 from $24 while maintaining an Outperform rating.

ARIS Stock Update: March 7, 2024 – Potential for Future Growth

On March 7, 2024, ARIS stock closed at $11.48, a decrease of $0.26 or 2.21% from the previous market close. In after-hours trading, the stock dropped another $0.26. Despite this decline, ARIS is still trading in the middle of its 52-week range and above its 200-day simple moving average, indicating relative stability over the long term. Investors may be watching closely to see if the stock can rebound from this drop and should monitor any upcoming news or developments that could impact its performance. Overall, while ARIS experienced a setback on March 7, its position within its 52-week range and above its 200-day moving average suggest potential for future growth. Investors should stay informed about any relevant market news.

ARIS Stock Reports Strong Growth in Revenue and Net Income for the Past Year, Flat Performance in Fourth Quarter

On March 7, 2024, ARIS stock had a mixed performance as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, ARIS reported a total revenue of $392.12 million for the past year, which represents a 22.15% increase compared to the previous year. However, the total revenue remained flat compared to the previous quarter, with the company reporting $104.12 million in revenue for the fourth quarter.

In terms of net income, ARIS reported a net income of $18.89 million for the past year, which marks a significant increase of 1011.06% compared to the previous year. Similar to the total revenue, the net income held flat since the previous quarter, with the company reporting $5.40 million in net income for the fourth quarter.

Earnings per share (EPS) also showed a significant increase for ARIS, with the company reporting an EPS of $0.59 for the past year, representing a staggering 1306.43% increase compared to the previous year. However, similar to the total revenue and net income, the EPS held flat since the previous quarter, with the company reporting an EPS of $0.17 for the fourth quarter.

Overall, ARIS stock showed strong growth in terms of total revenue, net income, and EPS compared to the previous year. However, the performance remained flat since the previous quarter, which may have impacted the stock performance on March 7, 2024. Investors will be closely monitoring the company’s future financial results to assess its growth potential and stock performance in the coming quarters.

Tags: ARIS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
SO stock news

Analyst Edward Kelly Maintains Underweight Rating on United Natural Foods Lowers Price Target

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

DrugRetailers Trading online

Arhaus Reports Surprising Quarterly Earnings Beat

Recommended

Tech-Innovations

Analyst Reaffirms Overweight Rating for Marvell Technology with Increased Price Target

1 year ago
Healthcare Services Stock Exchange

bioAffinity Technologies Inc Receives Patent in India for Innovative Cancer Treatment Technology

2 years ago

SpringWorks Therapeutics Reports Strong Q4 Results and Promising Pipeline Ahead

2 years ago
CL stock news

Vestor Capital LLC Boosts Stake in Colgate-Palmolive, Demonstrating Confidence in Consumer Goods Giant

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB Adobe ADSK ALB AMD AMZN Apple AVGO BA C COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM IBM INTC Intel LLY META Micron MP Materials MSFT NFLX NIO NVDA NVO Palantir PARA PLTR Red Cat Robinhood SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Verrica Shares Defy Strong Earnings with Persistent Decline

Regulatory Setback for Rival Positions Ocular Therapeutix for Major Market Opportunity

Summit Hotel Properties Maintains Dividend Amid Challenging Quarter

Quanterix Faces Investor Skepticism Despite Scientific Progress

Empire Petroleum Shares Exhibit Sharp Swings Following Capital Raise

Mixed Signals from ASML Earnings Leave Investors Puzzled

Trending

Context Therapeutics Stock
Stocks

Leadership Confidence: Context Therapeutics Insiders Make Significant Purchases Amid Market Volatility

by Andreas Sommer
August 29, 2025
0

While Context Therapeutics shares experience typical short-term fluctuations, the company's leadership has demonstrated notable conviction through their...

Merchants Stock

Executive Purchase Signals Confidence in Merchants Bancorp Despite Profit Plunge

August 29, 2025
Nerdwallet Stock

Nerdwallet Stock: A Study in Contrasting Market Sentiment

August 29, 2025
Verrica Stock

Verrica Shares Defy Strong Earnings with Persistent Decline

August 29, 2025
Ocular Therapeutix Stock

Regulatory Setback for Rival Positions Ocular Therapeutix for Major Market Opportunity

August 29, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Leadership Confidence: Context Therapeutics Insiders Make Significant Purchases Amid Market Volatility August 29, 2025
  • Executive Purchase Signals Confidence in Merchants Bancorp Despite Profit Plunge August 29, 2025
  • Nerdwallet Stock: A Study in Contrasting Market Sentiment August 29, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com